date,title,source
Oct-17-18,Onconova Therapeutics Announces Issuance of a New U.S. Patent for Rigosertib,GlobeNewswire
Oct-29-18,"Onconova Therapeutics to Meet with Potential Investors and Business Development Partners at the Bio-Europe 24th Annual International Partnering Conference in Copenhagen, Denmark",GlobeNewswire
Nov-01-18,"Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results",GlobeNewswire
Nov-05-18,Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition,GlobeNewswire
Nov-06-18,Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Nov-07-18,"Onconova Welcomes Richard (Ric) Woodman, M.D., as Chief Medical Officer (CMO)",GlobeNewswire
Nov-13-18,Edited Transcript of ONTX earnings conference call or presentation 13-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-13-18,Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018,GlobeNewswire
Nov-16-18,Edited Transcript of ONTX earnings conference call or presentation 13-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Dec-10-18,"Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel",GlobeNewswire
Dec-31-18,Onconova to Meet Investors and Potential Partners at China Focus and the 37th Annual J.P. Morgan Healthcare Conferences in San Francisco,GlobeNewswire
Jan-15-19,Onconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer,GlobeNewswire
Jan-16-19,Bucks County biopharm firm names new CEO,American City Business Journals
Jan-31-19,"Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City",GlobeNewswire
Mar-12-19,"Onconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA",GlobeNewswire
Mar-19-19,"Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results",GlobeNewswire
Mar-25-19,Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes,GlobeNewswire
Mar-26-19,Edited Transcript of ONTX earnings conference call or presentation 26-Mar-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-26-19,"Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results",GlobeNewswire
